Literature DB >> 17434836

Once-daily tigecycline therapy of multidrug-resistant and non-multidrug-resistant gram-negative bacteremias.

B A Cunha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434836     DOI: 10.1179/joc.2007.19.2.232

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


× No keyword cloud information.
  5 in total

1.  Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.

Authors:  Burke A Cunha
Journal:  J Clin Microbiol       Date:  2009-05       Impact factor: 5.948

2.  Tigecycline use in the outpatient parenteral antibiotic therapy setting.

Authors:  P R Ingram; M D M Rawlins; R J Murray; J A Roberts; L Manning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-20       Impact factor: 3.267

3.  Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.

Authors:  Mary L Townsend; Melanie W Pound; Richard H Drew
Journal:  Infect Drug Resist       Date:  2011-03-02       Impact factor: 4.003

4.  Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness.

Authors:  Jeffrey Baron; Shuntao Cai; Natalie Klein; Burke A Cunha
Journal:  J Clin Med       Date:  2018-03-09       Impact factor: 4.241

5.  Optimal therapy for multidrug-resistant Acinetobacter baumannii.

Authors:  Burke A Cunha
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.